35166-41-7 Usage
Uses
Used in Organic Synthesis:
(5-methyl-3-isoxazolyl)acetonitrile(SALTDATA: FREE) is used as a key intermediate in organic synthesis for the preparation of a wide range of chemical compounds. Its unique structure allows for various chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (5-methyl-3-isoxazolyl)acetonitrile(SALTDATA: FREE) is utilized as a building block for the development of new drugs. Its chemical properties enable it to be incorporated into the molecular structures of potential therapeutic agents, contributing to the discovery and creation of novel pharmaceuticals.
Used in Agrochemical Industry:
(5-methyl-3-isoxazolyl)acetonitrile(SALTDATA: FREE) also finds application in the agrochemical sector, where it serves as a precursor for the synthesis of various agrochemicals. Its role in this industry is crucial for the development of new pesticides, herbicides, and other agricultural chemicals that are essential for crop protection and yield enhancement.
Used as a Chemical Intermediate:
Beyond its direct applications, (5-methyl-3-isoxazolyl)acetonitrile(SALTDATA: FREE) is also used as an intermediate in the production of other chemicals. Its versatility in chemical reactions allows it to be a key component in the synthesis of a variety of chemical products, further expanding its utility across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 35166-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,1,6 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 35166-41:
(7*3)+(6*5)+(5*1)+(4*6)+(3*6)+(2*4)+(1*1)=107
107 % 10 = 7
So 35166-41-7 is a valid CAS Registry Number.
35166-41-7Relevant academic research and scientific papers
PEPTIDE EPOXYKETONE COMPOUNDS
-
Paragraph 00117; 00118, (2014/02/16)
The present disclosure relates to novel compounds and pharmaceutical compositions thereof which are useful as inhibitors of proteasomes. The compounds provided herein are capable of inhibiting all three of CT-L, T-L, and PGPH activities of proteasomes, and are useful in treating various conditions or diseases associated with proteasomes.
BENZO [B] ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF
-
Paragraph 00194; 00195, (2014/01/08)
The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS
-
Page/Page column 66, (2008/12/04)
The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease
Substituted enaminones, their derivatives and uses thereof
-
Page/Page column 19, (2010/11/25)
The present invention is related substituted enaminones represented by a compound of Formula I that are novel allosteric modulators of α7 nAChRs. The invention also discloses the treatment of disorders that are responsive to enhancement of acetylcholine a
